TY - JOUR
T1 - Erratum
T2 - Recurrent stroke: The role of thrombophilia in a large international pediatric stroke population (104:8(1676-1681) DOI:10.3324/haematol2018.211433)
AU - De Veber, Gabrielle
AU - Kirkham, Fenella
AU - Shannon, Kelsey
AU - Brandão, Leonardo
AU - Sträter, Ronald
AU - Kenet, Gili
AU - Clausnizer, Hartmut
AU - Moharir, Mahendranath
AU - Kausch, Martina
AU - Askalan, Rand
AU - MacGregor, Daune
AU - Stoll, Monika
AU - Torge, Antje
AU - Dlamini, Nomazulu
AU - Ganesan, Vijeja
AU - Prengler, Mara
AU - Singh, Jaspal
AU - Nowak-Göttl, Ulrike
N1 - Publisher Copyright:
© 2019 Ferrata Storti Foundation.
PY - 2019
Y1 - 2019
N2 - In the article pre-published online on January 24, 2019 and published in the paper version of Haematologica [volume 104(8):1676-1681; doi:10.3324/haematol2018.211433] we have to correct: • that recurrent stroke occurred in 160/872 (instead of 160 / 880) children [page 1678, second column, line 6]. • the incidence rates of recurrent AIS with respect to the individual exposure time in years given in the abstract (page 1676, lines 16-18) and in the results section (page 1679, paragraph "prothrombotic risk factors", lines 38-40). As explained in the methods section, we calculated the absolute risk of AIS recurrence as incidence rates per 100 patient-years (%). According to the individual exposure times (years) to antithrombin, lipoprotein (a) and the presence of more than one prothrombotic risk factor the incidence rates calculated per 100 patient-years are presented in the table below {table presented}.
AB - In the article pre-published online on January 24, 2019 and published in the paper version of Haematologica [volume 104(8):1676-1681; doi:10.3324/haematol2018.211433] we have to correct: • that recurrent stroke occurred in 160/872 (instead of 160 / 880) children [page 1678, second column, line 6]. • the incidence rates of recurrent AIS with respect to the individual exposure time in years given in the abstract (page 1676, lines 16-18) and in the results section (page 1679, paragraph "prothrombotic risk factors", lines 38-40). As explained in the methods section, we calculated the absolute risk of AIS recurrence as incidence rates per 100 patient-years (%). According to the individual exposure times (years) to antithrombin, lipoprotein (a) and the presence of more than one prothrombotic risk factor the incidence rates calculated per 100 patient-years are presented in the table below {table presented}.
UR - http://www.scopus.com/inward/record.url?scp=85072848199&partnerID=8YFLogxK
U2 - 10.3324/haematol.2019.234666
DO - 10.3324/haematol.2019.234666
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???
C2 - 31575673
AN - SCOPUS:85072848199
SN - 0390-6078
VL - 104
SP - 2116
JO - Haematologica
JF - Haematologica
IS - 10
ER -